Free HLA typing for children with thalassaemia launched in India

The initiative by DKMS Foundation India is for below 12 years children suffering from transfusion-dependent thalassemia

GRIN Therapeutics launches Phase 3 beeline study in Europe for radiprodil in GRIN-NDD

This is an exciting and meaningful milestone for GRIN Therapeutics

Lilly’s Omvoh shows rare long-term remission milestone in ulcerative colitis

Eli Lilly unveils $4.5 bn Indiana expansion

The investment will upgrade and expand production capabilities at Lilly Lebanon API and Lilly Lebanon Advanced Therapies

FDA advisory panel backs AstraZeneca prostate cancer combo in decisive vote

The Committee backed the combination based on results from the CAPItello-281 Phase III trial, marking a key milestone in the regulatory pathway for AstraZeneca’s targeted therapy strategy in prostate cancer

FDA grants breakthrough status to Laguna's mRNA blood test for schizophrenia diagnosis

The move puts a spotlight on one of psychiatry’s most persistent clinical challenges: misdiagnosis and delay

Aakash Healthcare publishes landmark study on integrated emergency clinical codes

Study introduces structured, condition-specific emergency coding system to improve coordination, response time, and patient safety in tertiary care hospitals

India's healthcare policymakers call for digital health expansion and system strengthening

Two-day long National Health Summit highlighted progress under the NHM and called for data-driven and SDG-aligned health system reforms

Merck KGaA launches Phase 3 push for lupus skin disease with enpatoran trials

The trials -- ELOWEN-1 and ELOWEN-2 -- are designed to evaluate the drug in people living with lupus who experience active skin manifestations

Pfizer drug delivers breakthrough in late-stage blood cancer trial

Patients receiving ELREXFIO largely remained free from disease progression during the interim analysis